Joachim M Baehring MD
Associate Professor of Neurology, of Medicine (Medical Oncology) and of Neurosurgery; Clinical Program Leader, Brain Tumor Program, Smilow Cancer Hospital
Molecular markers of cancer; Nervous system lymphoma
The primary foci of Dr. Baehring's laboratory work are primary brain tumors and neurological complications of cancer.
Dr. Baehring is involved in clinical and translational research at Yale University School of Medicine. He is an investigator for the national tumor consortia RTOG (Radiation Therapy Oncology Group) and ECOG (Eastern Cooperative Oncology Group). Other research interests include the molecular pathogenesis and development of molecular markers for primary CNS lymphoma.
- Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma.
Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J.
- Leukoencephalopathy in adults: Is it adrenoleukodystrophy? A case report and molecular analysis.
Dohle CI, Bannykh SI, Hisama FM, Baehring JM.
J Neurol Sci. 2009 Jul 8.
- Unusual presentations of nervous system infection by Cryptococcus neoformans.
Eric Searls D, Sico JJ, Bulent Omay S, Bannykh S, Kuohung V, Baehring J.
Clin Neurol Neurosurg. 2009 Sep;111(7):638-42. Epub 2009 Jun 21.
- Anaplastic oligoastrocytoma in Turcot syndrome.
Baehring J, Hui P, Piepmeier J, Bannykh SI.
J Neurooncol. 2009 Jun 4.
- A silver lining on the horizon for glioblastoma.
Knisely JP, Baehring JM.
Lancet Oncol. 2009 May;10(5):434-5.